Ligandrol (LGD-4033, VK5211) — Research Compounds Library | RetatrutideCompare
One of the most studied SARMs in early-phase human trials. Phase 1 healthy-volunteer studies showed dose-dependent lean-mass gains and transient HDL/SHBG suppression.
One of the most studied SARMs in early-phase human trials. Phase 1 healthy-volunteer studies showed dose-dependent lean-mass gains and transient HDL/SHBG suppression.